C5 and type 2 diabetes mellitus: These findings suggest that SCFAs could play a crucial protective role against kidney injury in T2DM by preventing the excessive activation of complement C5 and reducing the chemotaxis of inflammatory cells, thereby mitigating inflammation and tissue damage.